The Addressing STIs: Ask, Test, Treat, Repeat. intervention seeks to address the rising rates of sexually transmitted infections (STIs) in the United States over the past several years.
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.